All deaths are unfortunate but deaths of vulnerable populations have a greater emotional impact. Among these populations the foremost is women and children. Developing countries face the dual hardship of trying to both decrease maternal mortality and as well as child mortality. Birth asphyxia is the fifth largest cause of under-five child deaths (8.5%), after pneumonia, diarrhoea, neonatal infections and complications of preterm birth. Birth asphyxia accounts for an estimated 0.92 million neonatal deaths annually and is associated with another 1.1 million intrapartum stillbirths, as well as an unknown burden of long-term neurological disability and impairment. In this case of birth asphyxia, all events and circumstances of the pregnancy were favourable until the actual delivery. Unfortunately here, despite all measures taken to save a child that should have been a low risk candidate for birth asphyxia; the baby could not be saved. The treatment and management of birth asphyxia still has a long way to go so as to not only reduce morbidity but most importantly reduce mortality.
|Number of pages||4|
|Journal||Research Journal of Pharmaceutical, Biological and Chemical Sciences|
|Publication status||Published - 01-09-2016|
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology, Toxicology and Pharmaceutics(all)